Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy

Carbon-ion radiotherapy (CIRT) is a high linear energy transfer radiotherapy with good dose-localizing properties that is being gradually used across Europe and Asia [1]. It delivers a high dose of radiation to the target tissue, while avoiding the adjacent critical organs-at-risk. Consequently, promising outcomes of CIRT for inoperable radioresistant malignancies such as malignant mucosal melanomas, adenoid cystic carcinomas (ACC), adenocarcinomas, and head and neck sarcomas have been reported [2 –5].

Source: Radiotherapy and Oncology - April 18, 2019 Category: Radiology Authors: Kazuhiko Hayashi, Masashi Koto, Hiroaki Ikawa, Yasuhito Hagiwara, Hiroshi Tsuji, Kazuhiko Ogawa, Tadashi Kamada Tags: Original Article Source Type: research